"As a leading medical research facility, Phoenix Medical Research is dedicated to providing the facts and insights that will enable pharmaceutical companies and medical device manufacturers to pioneer the medical advances of tomorrow. Our exceptional resources have made us the preferred choice for both medical study participants and sponsors to perform a wide range of clinical trials. Our experience, knowledge, and expertise enable us to improve the outcomes for patients, as well as advance new concepts in the medical field. Centrally located in Phoenix, Arizona, with convenient access to the entire Southwest, our state-of-the-art facility is well-equipped to accommodate the demands of even the most rigorous medical studies."

During the past decade, Phoenix Medical Research Institute LLC conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phoenix Medical Research Institute LLC" #1 sponsor was "Kowa Research Institute, Inc." with 2 trials, followed by "Baxalta now part of Shire" with 1 trials sponsored, "Bellus Health Inc" with 1 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phoenix Medical Research Institute LLC" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Phoenix Medical Research Institute LLC" are "Chronic Obstructive Pulmonary Disease" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Alpha1-antitrypsin Deficiency" (1 trials), "COPD" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Phoenix Medical Research Institute LLC" in a lesser frequency.

Most popular intervention types in "Phoenix Medical Research Institute LLC" are "Drug" (6 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials) and "ARALAST NP 120 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Phoenix Medical Research Institute LLC" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Phoenix Medical Research Institute LLC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Phoenix Medical Research Institute LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Phoenix Medical Research Institute LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".